Back
Lyra Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
LYRA
Lyra Therapeutics
Last Price:
$8.48
Seasonality Move:
-2.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing slight buying pressure.
Lyra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.04 | Sell |
20-day SMA: | 10.17 | Sell |
50-day SMA: | 9.76 | Sell |
200-day SMA: | 9.63 | Sell |
8-day EMA: | 6.37 | Buy |
20-day EMA: | 3.53 | Buy |
50-day EMA: | 1.63 | Buy |
200-day EMA: | 0.44 | Buy |
Lyra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.2 | Buy |
Relative Strength Index (14 RSI): | 43.46 | Sell |
Chaikin Money Flow: | 5349 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.97 - 14.99) | Sell |
Bollinger Bands (100): | (4 - 13.1) | Buy |
Lyra Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lyra Therapeutics Stock
Is Lyra Therapeutics Stock a Buy?
-
Lyra Therapeutics share price is 8.71 while LYRA 8-day simple moving average is 9.04, which is a Sell signal.
-
The stock price of LYRA is 8.71 while Lyra Therapeutics 20-day SMA is 10.17, which makes it a Sell.
-
Lyra Therapeutics 50-day simple moving average is 9.76 while LYRA share price is 8.71, making it a Sell technically.
-
LYRA stock price is 8.71 and Lyra Therapeutics 200-day simple moving average is 9.63, creating a Sell signal.
LYRA Technical Analysis vs Fundamental Analysis
Sell
18
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy or a Sell?
-
Lyra Therapeutics stock is rated a SellThe current Lyra Therapeutics [LYRA] share price is $8.71. The Score for LYRA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Lyra Therapeutics Stock Info
Market Cap:
11.5M
Price in USD:
8.71
Share Volume:
17.8K
Lyra Therapeutics 52-Week Range
52-Week High:
37.50
52-Week Low:
3.81
Sell
18
Lyra Therapeutics (LYRA)
is a Sell
Lyra Therapeutics Share Price Forecast
-
What is the Lyra Therapeutics stock price today?The Lyra Therapeutics stock price is 8.71 USD today.
-
Will LYRA stock go up or go down?Lyra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lyra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyra Therapeutics is overvalued.
Is Lyra Therapeutics Stock a Buy?
-
Lyra Therapeutics share price is 8.71 while LYRA 8-day exponential moving average is 6.37, which is a Buy signal.
-
The stock price of LYRA is 8.71 while Lyra Therapeutics 20-day EMA is 3.53, which makes it a Buy.
-
Lyra Therapeutics 50-day exponential moving average is 1.63 while LYRA share price is 8.71, making it a Buy technically.
-
LYRA stock price is 8.71 and Lyra Therapeutics 200-day simple moving average is 0.44, creating a Buy signal.
Fundamental Analysis of Lyra Therapeutics
Is Lyra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Technical Analysis of Lyra Therapeutics
Should I short Lyra Therapeutics stock?
-
LYRA Moving Average Covergence Divergence (MACD) indicator is 2.2, suggesting Lyra Therapeutics is a Buy
-
Lyra Therapeutics Relative Strength Index (RSI) is 43.46, which suggest Lyra Therapeutics is oversold
-
The Bollinger Bands (25) for Lyra Therapeutics is (7.97 - 14.99), which suggest Lyra Therapeutics is a Buy
-
The Bollinger Bands (100) for Lyra Therapeutics is (4 - 13.1), which suggest Lyra Therapeutics is a Buy
* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.